New lupus drug targets immune system in early human trial
NCT ID NCT07011043
Summary
This is an early safety study of an experimental drug called budoprutug for adults with active systemic lupus erythematosus (SLE). The main goal is to see if different single doses are safe and well-tolerated in about 30 participants whose lupus hasn't responded well to standard treatments. Researchers will also track how the drug behaves in the body and its effect on specific immune cells (B cells) involved in lupus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Climb Bio Investigative Site #100101
RECRUITINGSan Antonio, Texas, 78215, United States
-
Climb Bio Investigative Site #100103
RECRUITINGCaguas, Puerto Rico
-
Climb Bio Investigative Site #100104
RECRUITINGAllen, Texas, 75013, United States
-
Climb Bio Investigative Site #380101
RECRUITINGTernopil, Ukraine
-
Climb Bio Investigative Site #380102
RECRUITINGIvano-Frankivsk, Ukraine
-
Climb Bio Investigative Site #380103
RECRUITINGKyiv, Ukraine
-
Climb Bio Investigative Site #380104
RECRUITINGVinnytsia, Ukraine
-
Climb Bio Investigative Site #380105
RECRUITINGVinnytsia, Ukraine
-
Climb Bio Investigative Site #380106
RECRUITINGKyiv, Ukraine
-
Climb Bio Investigative Site #995101
RECRUITINGTbilisi, 0141, Georgia
-
Climb Bio Investigative Site #995102
RECRUITINGTbilisi, 0112, Georgia
-
Climb Bio Investigative Site# 300102
NOT_YET_RECRUITINGExochi, Thessaloniki, 57010, Greece
-
Climb Bio Investigative Site# 300103
NOT_YET_RECRUITINGThessaloniki, Thessaloniki, 54642, Greece
-
Climb Bio Investigative Site# 340101
NOT_YET_RECRUITINGSabadell, Barcelona, 08208, Spain
-
Climb Bio Investigative Site# 340102
NOT_YET_RECRUITINGA Coruña, 15006, Spain
-
Climb Bio Investigative Site# 359101
RECRUITINGPlovdiv, 4002, Bulgaria
-
Climb Bio Investigative Site# 359102
RECRUITINGSofia, 1618, Bulgaria
-
Climb Bio Investigative Site# 400101
RECRUITINGCluj-Napoca, 400006, Romania
Conditions
Explore the condition pages connected to this study.